Evaluation of the efficacy and safety to dual oral therapy with daclatasvir and asunaprevir in Japanese reallife settings

被引：0
|
作者：
Sezaki, Hitomi [1 ]
Suzuki, Fumitaka [1 ]
Hosaka, Tetsuya [1 ]
Fujiyama, Shunichiro [1 ]
Kunimoto, Hideo [1 ]
Sorin, Yushi [1 ]
Kawamura, Yusuke [1 ]
Akuta, Norio [1 ]
Kobayashi, Masahiro [1 ]
Suzuki, Yoshiyuki [1 ]
Saitoh, Satoshi [1 ]
Arase, Yasuji [1 ]
Ikeda, Kenji [1 ]
Kobayashi, Mariko [2 ]
Kumada, Hiromitsu [1 ]
机构：
[1] Toranomon Gen Hosp, Hepatol, Tokyo, Japan
[2] Toranomon Gen Hosp, Res Inst Hepatol, Kawasaki, Kanagawa, Japan
来源：
HEPATOLOGY | 2015年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1191
引用
收藏
页码：799A / 799A
页数：1
相关论文
共 50 条
  • [1] The efficacy and safety of dual oral therapy with daclatasvir and asunaprevir for genotype 1b in Japanese real-life settings
    Sezaki, Hitomi
    Suzuki, Fumitaka
    Hosaka, Tetsuya
    Akuta, Norio
    Fujiyama, Shunichiro
    Kawamura, Yusuke
    Kobayashi, Masahiro
    Suzuki, Yoshiyuki
    Saitoh, Satoshi
    Arase, Yasuji
    Ikeda, Kenji
    Kobayashi, Mariko
    Kumada, Hiromitsu
    LIVER INTERNATIONAL, 2017, 37 (09) : 1325 - 1333
  • [2] Efficacy and safety of dual therapy with daclatasvir and asunaprevir in elderly patients
    Kazuo Tarao
    Katsuaki Tanaka
    Akito Nozaki
    Akira Sato
    Toshiya Ishii
    Hirokazu Komatsu
    Takaaki Ikeda
    Tatsuji Komatsu
    Shozo Matsushima
    Kenji Oshige
    World Journal of Hepatology, 2017, (11) : 544 - 550
  • [3] Therapeutic effect of dual oral therapy with Daclatasvir and Asunaprevir
    Kohjima, Motoyuki
    Motomura, Kenta
    Koyanagi, Toshimasa
    Tada, Seiya
    Satoh, Takeaki
    Yamashita, Naoki
    Yokota, Masaki
    Sugimoto, Rie
    Nagase, Syoji
    Morizono, Syusuke
    Higuchi, Nobito
    Yoshimoto, Tsuyoshi
    Tashiro, Shigeki
    Tanaka, Yuki
    Fukuizumi, Kunitaka
    Kotoh, Kazuhiro
    Nakamuta, Makoto
    HEPATOLOGY, 2015, 62 : 781A - 782A
  • [4] Safety and efficacy of dual therapy with daclatasvir and asunaprevir for older patients with chronic hepatitis C
    Reona Morio
    Michio Imamura
    Yoshiiku Kawakami
    Kei Morio
    Tomoki Kobayashi
    Satoe Yokoyama
    Yuki Kimura
    Yuko Nagaoki
    Tomokazu Kawaoka
    Masataka Tsuge
    Akira Hiramatsu
    C. Nelson Hayes
    Hiroshi Aikata
    Shoichi Takahashi
    Daiki Miki
    Hidenori Ochi
    Nami Mori
    Shintaro Takaki
    Keiji Tsuji
    Kazuaki Chayama
    Journal of Gastroenterology, 2017, 52 : 504 - 511
  • [5] Safety and efficacy of dual therapy with daclatasvir and asunaprevir for older patients with chronic hepatitis C
    Morio, Reona
    Imamura, Michio
    Kawakami, Yoshiiku
    Morio, Kei
    Kobayashi, Tomoki
    Yokoyama, Satoe
    Kimura, Yuki
    Nagaoki, Yuko
    Kawaoka, Tomokazu
    Tsuge, Masataka
    Hiramatsu, Akira
    Hayes, C. Nelson
    Aikata, Hiroshi
    Takahashi, Shoichi
    Miki, Daiki
    Ochi, Hidenori
    Mori, Nami
    Takaki, Shintaro
    Tsuji, Keiji
    Chayama, Kazuaki
    JOURNAL OF GASTROENTEROLOGY, 2017, 52 (04) : 504 - 511
  • [6] Early response and efficacy of dual oral therapy with asunaprevir and daclatasvir for elderly patients with hepatitis C
    Honda, Takashi
    Ishigami, Masatoshi
    Ishizu, Yoji
    Kuzuya, Teiji
    Hayashi, Kazuhiko
    Hirooka, Yoshiki
    Goto, Hidemi
    HEPATOLOGY, 2015, 62 : 786A - 786A
  • [7] EARLY HCV KINETICS DURING DUAL ORAL THERAPY WITH DACLATASVIR AND ASUNAPREVIR
    Nakamuta, M.
    Kohjima, M.
    Motomura, K.
    Tabata, S.
    Koyanagi, T.
    Yamashita, N.
    Sato, T.
    Yokota, M.
    Higuchi, N.
    Yoshimoto, T.
    Kurashige, T.
    Kawamoto, M.
    Fukuizumi, K.
    Kotoh, K.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S648 - S649
  • [8] New resistance-associated variants and failure of dual oral therapy with daclatasvir and asunaprevir
    Mawatari, Seiichi
    Moriuchi, Akihiro
    Ijuin, Sho
    Sakae, Haruka
    Taniyama, Oki
    Tabu, Kazuaki
    Oshige, Akihiko
    Oda, Kohei
    Tamai, Tsutomu
    Ido, Akio
    HEPATOLOGY, 2016, 64 : 445A - 446A
  • [9] New resistance-associated substitutions and failure of dual oral therapy with daclatasvir and asunaprevir
    Seiichi Mawatari
    Kohei Oda
    Kazuaki Tabu
    Sho Ijuin
    Kotaro Kumagai
    Yukiko Inada
    Hirofumi Uto
    Yasunari Hiramine
    Takeshi Kure
    Kunio Fujisaki
    Masafumi Hashiguchi
    Takeshi Hori
    Akihiko Oshige
    Dai Imanaka
    Akiko Saishoji
    Oki Taniyama
    Haruka Sakae
    Tsutomu Tamai
    Akihiro Moriuchi
    Akio Ido
    Journal of Gastroenterology, 2017, 52 : 855 - 867
  • [10] New resistance-associated substitutions and failure of dual oral therapy with daclatasvir and asunaprevir
    Mawatari, Seiichi
    Oda, Kohei
    Tabu, Kazuaki
    Ijuin, Sho
    Kumagai, Kotaro
    Inada, Yukiko
    Uto, Hirofumi
    Hiramine, Yasunari
    Kure, Takeshi
    Fujisaki, Kunio
    Hashiguchi, Masafumi
    Hori, Takeshi
    Oshige, Akihiko
    Imanaka, Dai
    Saishoji, Akiko
    Taniyama, Oki
    Sakae, Haruka
    Tamai, Tsutomu
    Moriuchi, Akihiro
    Ido, Akio
    JOURNAL OF GASTROENTEROLOGY, 2017, 52 (07) : 855 - 867
12345